New Developments and Challenges in Transcatheter Treatments of Structural Heart Diseases

Dear Colleagues,

Structural heart disease (SHD) refers to conditions that affect the heart’s valves, walls, chambers or muscles, and is commonly found in daily practice. To offer the best therapeutic solution for patients, various heart specialists are often involved. Over the past few years, a great deal of effort was made to develop  the transcatheter treatments of SHD. The continuous increase in operators’ skills, in association with further engineering refinements, makes transcatheter treatments a contemporary gold-standard therapy for SHD. Advantages of less invasive therapies are unequivocally clear and allow us to expand treatment indications to a broader and increasingly more complex population of patients. Similarly, it is important to keep in mind that several challenges still exist in this field, and new attempts to minimize the risk of complication are an ongoing priority. New devices and techniques to treat valves, septal defects and other issues associated with SHD have emerged on the market to improve the efficacy and safety of SHD procedures. For this reason, this Special Issue will present innovations and emerging findings concerning transcatheter treatments of SHD.

Dr. Andrea Buono
Dr. Elisabetta Moscarella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.